Accedi a banche dati online | Convegnodetail
Anteprima di stampa
 
 

2nd Gene Therapy for Ophthalmic Disorders

Evvnt Promotion / evvnt
-
21.09.2021 - 23.09.2021  Online
Time: 8:00 am - 5:00 pm
 
Temi della conferenza
Returning in September as a digital event, the 2nd Gene Therapy for Ophthalmic Disorders meeting will target the industry’s translational challenges in targeting both rare and common ophthalmic disorders including wet AMD, dry AMD, DME, IRDs and more.

Discover novel vectors and administration routes for optimal retinal delivery with 30+ world class speakers from the likes of GenSight Biologics, Biogen, Gyroscope Therapeutics, Novartis, Horama and REGENXBIO.
Scientific organizer
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/780504-0?pid=4832

Speakers: Nicolas Ferry, Chief Development Officer, HORAMA, Rei Nakamura, Clinical Country Lead, Biogen and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/780504-1?pid=4832
Ms. Ellie Saunders
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 1599.00 - USD 3296.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioAMREF - African Medical and Research FoundationEuropean Public Health Association (EUPHA)AGEM - Arbeitsgemeinschaft Ethnologie und MedizinSwiss Tropical and Public Health InstituteAnästhesie in Entwicklungsländern e. V.Charité International AcademynewTree